Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: Analysis of the MOST database

Transplantation Proceedings

Volumn 37, Issue 6, 2005, Pages 2464-2466

  Salvadori, M ^l   Bock, A ^a   Chapman, J ^b   Dussol, B ^c   Fritsche, L ^m   Kliem, V ^m   Lebranchu, Y ^d,e,f   Oppenheimer, F ^g   Pohanka, E ^h   Tufveson, G ⁱ   Rosati, A ^j   Puig, X ^k   Corbetta, G ^k  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b WESTMEAD HOSPITAL   (Australia)

^c HÔPITAL DE LA CONCEPTION   (France)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Medizinische Poliklinik   (Germany)

^f CHU BRETONNEAU   (France)

^g HOSPITAL CLÍNIC   (Spain)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁱ UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^j Universitaria Careggi   (Italy)

^k NOVARTIS PHARMA AG   (Switzerland)

^l Azienda Ospedaliero Universitaria Careggi   (Italy)

^m NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GRAFT REJECTION; ADULT; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DATA ANALYSIS; DATA BASE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT;

EID: 25144498751     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.06.053     Document Type: Article

References (10)

1. P. Keown A blinded, randomized clinical trial of Mycophenolate Mofetil for the prevention of acute rejection in cadaveric renal transplantation (Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group) Transplantation 61 1996 1029
2. R. Pichlmayr Placebo-controlled study of Mycophenolate Mofetil combined with Cyclosporin and Corticosteroids for prevention of acute rejection (European Mycophenolate Mofetil Cooperation Study Group) Lancet 245 1995 1321
3. H. Sollinger US Renal Transplant Mycophenolate Mofetil Study Group Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients Transplantation 60 1995 225
4. G. Offermann Five-year results of renal transplantation on immunosuppressive triple therapy with mycophenolate mofetil Clin Transplant 17 2003 43
5. M. Hale, A.J. Nicholls, R.E. Bullingham Clin Pharmacol Ther 64 1998 672
6. M. Behrend Adverse gastrointestinal effects of mycophenolate mofetil. Aetiology, incidence and management Drug Safety 24 2001 645
7. A. Greg, G.A. Knoll, I. Macdonald Mycophenolate Mofetil dose reduction and the risk of acute rejection after renal transplantation J Am Soc Nephrol 14 2003 2381
8. R.P. Pelletier, B. Akin The impact of Mycophenolate Mofetil dosing patterns on clinical outcome after renal transplantation Clin Transplant 17 2003 200
9. D.W. Cockcroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31
10. M. Salvadori, A. Rosati, A. Bock One-year posttransplant renal function is a strong predictor of long-term kidney function results from the Neoral-MOST Observational Study Transplant Proc 35 2003 2863